0920-24EH OHZDP Post Workshop Survey

Form Approved

OMB Control No.: 0920-1154

Expiration date: 03/31/2026

Post-Workshop Survey

INTRODUCTION

Thank you for taking the time to complete this post-workshop survey! This survey supports ongoing evaluation of CDC’s One Health Zoonotic Disease Prioritization (OHZDP) Process to measure the impact of the OHZDP around the world. The purpose of this survey is to learn how locations have advanced One Health efforts since engaging in the OHZDP Process.

This survey will be issued at three time points (6 months, 1.5 years, and 3 years after your OHZDP workshop). After completing each survey, you will be able to track your location’s progress to advance One Health and address the priority zoonotic diseases since the OHZDP workshop.

Information provided may be used by CDC for monitoring and evaluation. Responses may be aggregated with other locations in a summary report on OHZDP impacts globally.

NOTES:

• This survey should be completed by the core planning team to incorporate perspectives across One Health sectors about ongoing One Health and zoonotic disease activities in your location.

• It may be helpful to have your location’s OHZDP workshop report available on hand while completing the survey. Completed OHZDP workshop reports can be found here: Completed OHZDP Workshops | One Health | CDC. If your report is not yet published, but you are requesting a copy to support the completion of this survey, please contact [email protected]

• One Health sectors refers to the government sectors responsible for threats at the human-animal-environmental interface in your location (e.g. public health, animal health (domestic and wildlife), and environment).

• Please include outcomes regardless of what sector accomplished the activity.

• The sections in this survey were identified for the purpose of categorizing One Health outcomes and may differ from your workshop’s categorizations. However, please review and mark all applicable outcomes regardless of which category they are listed under.

1. How would you rate One Health Coordination in your location?

1 Very poor

2 Poor

3 Fair

4 Good

5 Very good

2. Please indicate below which of the following outcomes were accomplished since [YYYY] for ONE HEALTH COORDINATION as a direct result of conducting the OHZDP workshop in (country, year):

☐ [Established or enhanced] a formal multisectoral, One Health coordination mechanism with decision making authority and acts to strengthen or develop collaboration, communication, and coordination across the sectors responsible for addressing zoonotic diseases

☐ [Established or enhanced] informal multisectoral, One Health coordination mechanism for addressing zoonotic diseases

☐ Used the Tripartite Zoonoses Guide Multisectoral, One Health Coordination Mechanism Operational Tool (MCM OT)

☐ [Established or increased] political support for One Health and/or the priority zoonotic diseases

☐ Disseminated OHZDP workshop outcomes

☐ [Established or updated] legislation for One Health coordination☐ [Developed or updated] One Health strategic plan or national framework

☐ [Developed or updated] One Health action plans (One Health operational plans, implementation plans)

☐ [Developed or updated] Memorandums of Understanding (MoU) or Memorandums of Agreement (MoA) across One Health sectors

☐ [Established or enhanced] technical working groups for any of the priority zoonotic diseases

☐ Met regularly across One Health sectors to address any of the priority zoonotic diseases

☐ [Established or increased] funding for any of the priority zoonotic diseases

☐ Conducted OHZDP workshops at the subnational level

☐ Conducted a One Health capacity assessment and/or needs assessment

☐ Other for One Health coordination outcomes from OHZDP: text optional ____________________________

3. Please indicate below which of the following outcomes were accomplished since [YYYY] for SURVEILLANCE CAPACITY as a direct result of conducting the OHZDP workshop in (country, year):

☐ Conducted surveillance assessments/evaluations for any of the priority zoonotic diseases

☐ [Developed or updated] a strategy or plan for coordinated surveillance for any of the priority zoonotic diseases across One Health sectors

☐ Used the Tripartite Zoonoses Guide Surveillance and Information Sharing Operational Tool (SISOT)

☐ Used other One Health tool(s) to enhance surveillance for any of the priority zoonotic diseases across sectors

☐if selected: Specify tool(s):________________

☐ Incorporated any of the priority zoonotic diseases into surveillance systems

☐ [Developed or improved] systems for sharing surveillance data and information for any of the priority zoonotic diseases across One Health sectors

☐ [Collected or increased] epidemiologic data for any of the priority zoonotic diseases

☐ Developed or coordinated case definitions across One Health sectors for any of the priority zoonotic diseases

☐ Other for surveillance outcomes from OHZDP: -----text optional

4. Please indicate below which of the following outcomes were accomplished since [YYYY] for LABORATORY CAPACITY as a direct result of conducting the OHZDP workshop in (country, year):

☐ Conducted laboratory assessments/evaluations for any of the priority zoonotic diseases

☐ [Developed or updated] a strategy or plan for strengthening laboratory capacity for any of the priority zoonotic diseases across One Health sectors

☐ [Established or improved] a mechanism for routine laboratory data and information sharing for priority zoonotic diseases across One Health sectors

☐ Shared laboratory protocols for any priority zoonotic diseases between animal health and human health laboratories

☐ Procured laboratory equipment and supplies for any of the priority zoonotic diseases

☐ [Established or improved] diagnostic capacity (e.g. acquired diagnostics, decreased testing time, genomic sequencing etc.) for any of the priority zoonotic diseases

☐ [Collected or increased] samples to test for any of the priority zoonotic diseases

☐ Used a One Health tool(s) to enhance laboratory capacity for any of the priority zoonotic diseases

☐if selected: Specify tool(s):______________

☐ Other for laboratory outcomes from OHZDP: ----text optional

5. Please indicate below which of the following outcomes were accomplished since [YYYY] for PREPAREDNESS AND PLANNING as a direct result of conducting the OHZDP workshop in (country, year):

☐ [Developed or updated] joint preparedness plans for any of the priority zoonotic diseases across One Health sectors

☐ [Developed or updated] joint Standard Operating Procedures (SOPs) for any of the priority zoonotic diseases across One Health sectors

☐ Conducted a simulation exercise(s) for any of the priority zoonotic diseases

☐ Conducted a joint risk assessment for any of the priority zoonotic diseases

☐ Used the Tripartite Zoonoses Guide Joint Risk Assessment Operational Tool (JRA OT) for any of the priority zoonotic diseases

☐ Conducted WHO’s Preparedness and Response (RePrep) workshop

☐ [Conducted or increased] research activities for any of the priority zoonotic diseases

☐ Used other One Health tool(s) to support preparedness and planning for any of the priority zoonotic disease

☐if selected: Specify tool(s):______________

☐ Other preparedness and planning outcomes from OHZDP: ----text optional

6. Please indicate below which of the following outcomes were accomplished since [YYYY] for OUTBREAK RESPONSE as a direct result of conducting the OHZDP workshop in (country, year):

☐ [Established or improved] a protocol to conduct coordinated or joint investigations and responses for any of the priority zoonotic diseases across One Health sectors

☐ [Established and/or mobilized] trained One Health Rapid Response Teams

☐ Conducted joint investigation or response with One Health sectors for any of the priority zoonotic diseases

☐ [Involved or increased] involvement of other One Health sectors in an existing rapid response team

☐ Conducted a review (e.g. Early Action Review, After Action Review) for any of the priority zoonotic diseases during or after an investigation or response across One Health sectors

☐ Used a One Health tool(s) to support outbreak response for any of the priority zoonotic diseases:

☐if selected: Specify tool(s):______________

☐ Other for outbreak response outcomes from OHZDP: ----text optional

7. Please indicate below which of the following outcomes were accomplished since [YYYY] for PREVENTION AND CONTROL as a direct result of conducting the OHZDP workshop in (country, year):

☐ [Implemented or improved] prevention and control measures (e.g. vaccination or education campaigns, quarantine, culling, etc.) for any of the priority zoonotic diseases in coordination with the other One Health sectors

☐ [Developed or enhanced] a joint plan or policy document outlining prevention and control strategies for any of the priority zoonotic diseases (e.g. national plans)

☐ Procured resources (e.g. vaccines, treatment, etc.) for any of the priority zoonotic diseases

☐ [Developed or implemented] early prevention measures for any of the priority zoonotic diseases to prevent spillover from animals to people

☐ [Developed or implemented] early prevention measures for any of the priority zoonotic diseases to prevent spillback from people to animals

☐ Used a One Health tool(s) to support prevention and control for any of the priority zoonotic diseases

☐if selected: Specify tool(s):______________

☐ Other for prevention and control: ----text optional

8. Please indicate below which of the following outcomes were accomplished since [YYYY] for WORKFORCE CAPACITY as a direct result of conducting the OHZDP workshop in (country, year):

☐ Incorporated any of the priority zoonotic diseases into a strategy or plan for educating, training, or strengthening a One Health workforce

☐ [Conducted or enhanced] a review of current One Health workforce trainings

☐ Developed One Health curriculum for workforce training programs

☐ Conducted sector-specific trainings on any of the priority zoonotic diseases

☐ Conducted joint trainings across One Health sectors on any of the priority zoonotic diseases

☐ Used a One Health tool(s) to support One Health workforce capacity

☐if selected: Specify tool(s):______________

☐ Other workforce outcome from OHZDP: ----text optional

9. Please indicate below which of the following outcomes were accomplished since [YYYY] for RISK COMMUNICATION AND COMMUNITY EDUCATION as a direct result of conducting the OHZDP workshop in (country, year):

☐ [Developed or updated] a One Health strategy and plan for risk reduction, risk communication and/or community engagement for any of the priority zoonotic diseases

☐ [Established or improved] a platform to develop joint communications across One Health sectors

☐ [Developed or updated] a network, messaging group, or listserv of One Health partners for One Health information sharing

☐ [Developed or shared] educational materials on any of the priority zoonotic diseases for use during an outbreak/event

☐ [Established or increased] outreach or education to the community on any of the priority zoonotic diseases (e.g. social media, newsletters, brochures, etc.)

☐ Used a One Health tool for risk communication and community education for any of the priority zoonotic diseases

☐ Other risk communication and community education outcome from OHZDP: ----text optional

10. Were results from the OHZDP workshop incorporated into any of the following [mark all that apply]:

☐ Laws or regulations

☐ Funding proposals (e.g. Pandemic Fund)

☐ Joint External Evaluation

☐ International Health Regulations (IHR) State Party Self-Assessment Annual Report (SPAR)

☐ Pathway to Veterinary Services (PVS)

☐ IHR-PVS National Bridging Workshop

☐ National Action Plans for Health Security (NAPHS)

☐ National One Health Joint Plan of Action

☐ Global Laboratory Leadership Program

☐ Other -----text optional

11. Please select which of the priority zoonotic diseases were addressed by the accomplishments you indicated in any of the sections above:

Locations priority zoonotic disease list is included as check boxes.

☐ Priority zoonotic disease 1

☐ Priority zoonotic disease 2

☐ Priority zoonotic disease 3

☐ Priority zoonotic disease 4

☐ Priority zoonotic disease 5

12. Did you notice reduced burden of any of the priority zoonotic diseases as a result of the outcomes of the OHZDP Workshop?

☐ Yes (triggers priority zoonotic disease list checkbox)

☐ Priority zoonotic disease 1

☐ Priority zoonotic disease 2

☐ Priority zoonotic disease 3

☐ Priority zoonotic disease 4

☐ Priority zoonotic disease 5

☐ No

☐ Unsure

13. Would [LOCATION NAME] be willing to participate in a future OHZDP (e.g. regional, national, subnational, etc.) in the future?

☐ Yes

☐ No

14. Did [LOCATION NAME] conduct any other types of prioritizations using the OHZDP methodology (e.g. sector-specific, non-zoonotic disease, etc.)?

☐ Yes

☐if selected: Specify type of prioritization: ______________

☐ No

☐ Unsure

15. Please share any examples on how conducting an OHZDP workshop has impacted One Health and/or zoonotic diseases outcomes in your location. (optional)

16. Is there anything else you would like to share with CDC’s One Health Office? (optional)

17. Please provide your name and work email address if you would be willing to be contacted by CDC’s One Health Office for any follow up on your responses: (optional)

Thank you for taking the time to complete this post-workshop survey. Your participation and input are extremely valuable in evaluating the impacts of the OHZDP Process. You can now track your progress since the OHZDP workshop through the OHZDP Portal. Navigate to the “After the Workshop” section and select “Monitoring and Evaluation”, then select “Monitoring & Evaluation Dashboard” to view your progress.

If you have any further comments or questions, please feel free to contact CDC’s One Health Office at [email protected].

Public reporting burden of this collection of information is estimated to average 15 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information.  An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB Control Number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Reports Clearance Officer, 1600 Clifton Road NE, MS H21-8, Atlanta, Georgia 30333; ATTN: PRA 0920-1154